REDUCTION OF STEADY-STATE VALPROATE LEVELS BY OTHER ANTI-EPILEPTIC DRUGS

被引：61

作者：

SACKELLARES, JC

SATO, S

DREIFUSS, FE

PENRY, JK

机构：

[1] UNIV MICHIGAN, DEPT NEUROL, ANN ARBOR, MI 48109 USA

[2] NINCDS, EPILEPSY BRANCH, BETHESDA, MD 20205 USA

[3] UNIV VIRGINIA, MED CTR, DEPT NEUROL, CHARLOTTESVILLE, VA 22903 USA

[4] WAKE FOREST UNIV, BOWMAN GRAY SCH MED, WINSTON SALEM, NC 27103 USA

来源：

EPILEPSIA | 1981年 / 22卷 / 04期

关键词：

D O I：

10.1111/j.1528-1157.1981.tb06154.x

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：437 / 441

页数：5

共 20 条

[1]

BOWDLE TA, 1979, CLIN PHARMACOL THER, V26, P629

[2] VALPROIC ACID AND PLASMA-LEVELS OF PHENYTOIN [J].

BRUNI, J ;

WILDER, BJ ;

WILLMORE, LJ ;

BARBOUR, B .

NEUROLOGY, 1979, 29 (06) :904-905

[3] VALPROIC ACID - INVITRO PLASMA-PROTEIN BINDING AND INTERACTION WITH PHENYTOIN [J].

CRAMER, JA ;

MATTSON, RH .

THERAPEUTIC DRUG MONITORING, 1979, 1 (01) :105-116

[4] VALPROATE SODIUM - CONTROLLED CLINICAL-TRIAL INCLUDING MONITORING OF DRUG LEVELS [J].

GRAM, L ;

WULFF, K ;

RASMUSSEN, KE ;

FLACHS, H ;

WURTZJORGENSEN, A ;

SOMMERBECK, KW ;

LOHREN, V .

EPILEPSIA, 1977, 18 (02) :141-148

[5] PLASMA-PROTEIN BINDING OF VALPROIC ACID IN HEALTHY SUBJECTS AND IN PATIENTS WITH RENAL-DISEASE [J].

GUGLER, R ;

MUELLER, G .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 5 (05) :441-446

[6] CLINICAL PHARMACOKINETICS OF VALPROIC ACID [J].

GUGLER, R ;

UNRUH, GEV .

CLINICAL PHARMACOKINETICS, 1980, 5 (01) :67-83

[7]

KLOTZ U, 1977, CLIN PHARMACOL THER, V21, P736

[8]

KUPFERBERG HJ, 1978, ANTIEPILEPTIC DRUGS, P147

[9] VALPROIC ACID IN EPILEPSY - CLINICAL AND PHARMACOLOGICAL EFFECTS [J].

MATTSON, RH ;

CRAMER, JA ;

WILLIAMSON, PD ;

NOVELLY, RA .

ANNALS OF NEUROLOGY, 1978, 3 (01) :20-25

[10] VALPROIC ACID AND ETHOSUXIMIDE INTERACTION [J].

MATTSON, RH ;

CRAMER, JA .

ANNALS OF NEUROLOGY, 1980, 7 (06) :583-584

← 1 2 →